- This event has passed.
Valuation trends in U.S. and Ireland markets & life sciences: Insights for asset managers
January 23, 2025 @ 2:00 pm – 3:00 pm EST
Event description
Join us for an insightful discussion on asset manager valuation trends, with a special focus on the life sciences industry. This session will cover the latest valuation observations and opportunities in the U.S. and Ireland markets, specifically within the life sciences sector. Our valuation specialists will delve into the unique dynamics of the life sciences industry, including pharmaceuticals, medical devices, and biotechnology.
Key topics include:
- Observations and valuation considerations for the U.S. and Ireland markets
- Market performance and deal-making trends for the life sciences industry, across Big Pharma, biotech, and medical devices
- The cross-border history in the life sciences sector between Ireland and the U.S.
- Macro factors, focusing on trade relations between Ireland and the U.S. in the sector
- The latest trends in deal activity within the sector in Ireland, highlighting key developments and opportunities
- The U.S. tax debate agenda for 2025
We hope you will join us to explore these critical trends and developments.
Date and time
Thursday, January 23, 2025
2:00 PM ET – 3:00 PM ET
Recommended CPE credits
1
Learning objectives
Discuss the impact of potential U.S. tax and tariff changes on the life sciences industry
Identify and explain key valuation trends in the U.S. and Ireland markets and the life sciences industry, including specific examples from Big Pharma, biotech, and medical devices
Assess and evaluate the current state of the overall transactions market (M&A and capital markets) across the life sciences sector
Analyze and apply the impact of macroeconomic factors and trade relations on the valuation of life sciences companies and the broader market.
